• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Actonel tablets

Eisai: All-case Surveillance Condition for Approval of "Actonel 17.5 mg tablets" for Treatment of Paget's Disease of Bone Cleared in Japan
March 19, 2020
Pharmaceutical News

Eisai: All-case Surveillance Condition for Approval of “Actonel 17.5 mg tablets” for Treatment of Paget’s Disease of Bone Cleared in Japan

EA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has given notification of the results of reexamination to the effect that the “all-case surveillance” specified drug use-results survey condition required for the

More
Eisai: All-case Surveillance Condition for Approval of "Actonel 17.5 mg tablets" for Treatment of Paget's Disease of Bone Cleared in Japan
Pharmaceutical News

Eisai: All-case Surveillance Condition for Approval of “Actonel 17.5 mg tablets” for Treatment of Paget’s Disease of Bone Cleared in Japan

March 19, 2020

EA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare

More
  • Repurposing the anthelmintic drug Niclosamide
  • Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs
  • Pharmaceutical Equipment Manufacturer Unveils Custom Wash Rack Services 
  • Merging mind and machine: Augmented intelligence and the limits of AI in medical communications
  • Breaking Free from Addiction: Exploring Online Suboxone Clinics in San Antonio, TX

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop